Promoting proliferation of CRC via CCL3‐related molecular pathways,[75c] the RHEB/mTOR pathway,[76] mucosal bft exposure,[77] and spermine oxidase overexpresse.[47]. The gene discussed is MTOR; the disease is colorectal carcinoma.